everolimus

Generic: everolimus

Labeler: par health usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name everolimus
Generic Name everolimus
Labeler par health usa, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

everolimus 5 mg/1

Manufacturer
Par Health USA, LLC

Identifiers & Regulatory

Product NDC 49884-125
Product ID 49884-125_b474c768-50e2-44da-accf-f1bd3d49ab20
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207934
Marketing Start 2019-12-10
Marketing End 2026-07-31

Pharmacologic Class

Established (EPC)
kinase inhibitor [epc] mtor inhibitor immunosuppressant [epc]
Mechanism of Action
protein kinase inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] mtor inhibitors [moa]
Physiologic Effect
decreased immunologic activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49884125
Hyphenated Format 49884-125

Supplemental Identifiers

RxCUI
845507 845515 998189 1119400
UNII
9HW64Q8G6G
NUI
N0000175605 N0000175076 N0000182141 N0000182137 N0000175625 N0000175624 N0000175550

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name everolimus (source: ndc)
Generic Name everolimus (source: ndc)
Application Number ANDA207934 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 28 BLISTER PACK in 1 CARTON (49884-125-91) / 1 TABLET in 1 BLISTER PACK (49884-125-52)
source: ndc

Packages (1)

49884-125-91 28 BLISTER PACK in 1 CARTON (49884-125-91) / 1 TABLET in 1 BLISTER PACK (49884-125-52)

Ingredients (1)

everolimus (5 mg/1)

Linked Drug Pages (1)

Everolimus ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b474c768-50e2-44da-accf-f1bd3d49ab20", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "unii": ["9HW64Q8G6G"], "rxcui": ["845507", "845515", "998189", "1119400"], "spl_set_id": ["45d54974-3fc4-4237-a2fa-3158ca1a8105"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Par Health USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 BLISTER PACK in 1 CARTON (49884-125-91)  / 1 TABLET in 1 BLISTER PACK (49884-125-52)", "package_ndc": "49884-125-91", "marketing_end_date": "20260731", "marketing_start_date": "20191210"}], "brand_name": "Everolimus", "product_id": "49884-125_b474c768-50e2-44da-accf-f1bd3d49ab20", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "49884-125", "generic_name": "Everolimus", "labeler_name": "Par Health USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": "5 mg/1"}], "application_number": "ANDA207934", "marketing_category": "ANDA", "marketing_end_date": "20260731", "marketing_start_date": "20191210"}